Conecte-se

Bibliografias temáticas / Sickle cells diseases / Livros

Siga este link para ver outros tipos de publicações sobre o tema: Sickle cells diseases.

Livros sobre o tema "Sickle cells diseases"

Autor: Grafiati

Publicado: 12 de abril de 2025

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores livros para estudos sobre o assunto "Sickle cells diseases".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os livros das mais diversas áreas científicas e compile uma bibliografia correta.

1

Alvin, Silverstein, Silverstein Virginia B e Nunn Laura Silverstein, eds. What you can do about sickle cell disease. New York, NY: Enslow Publishing, 2016.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Peak, Lizabeth. Sickle cell disease. Detroit: Lucent Books, 2008.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Peak, Lizabeth. Sickle cell disease. Detroit: Lucent Books, 2008.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Serjeant, Graham R. Sickle cell disease. 2^a ed. Oxford: Oxford University Press, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

F, Whitten Charles, Bertles John F. 1925-, National Association for Sickle Cell Disease (U.S.) e New York Academy of Sciences., eds. Sickle cell disease. New York, N.Y: New York Academy of Sciences, 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Eboh, Winifred Oluchukwu. Sickle cell disease. (Birmingham): Birmingham Sickle Cell & Thalassaemia Centre, 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Jones, Phill. Sickle cell disease. New York: Chelsea House, 2008.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Samuel, Charache, e Johnson Cage S, eds. Sickle cell disease. Philadelphia: W.B. Saunders, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

McCormick, Marie, Henrietta Awo Osei-Anto e Rose Marie Martinez, eds. Addressing Sickle Cell Disease. Washington, D.C.: National Academies Press, 2020. http://dx.doi.org/10.17226/25632.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Beshore, George. Sickle cell anemia. New York: F. Watts, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

P, Rodgers Griffin, ed. Sickle cell disease and thalassaemia. London: Baillière Tindall, 1998.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

author, Chilman-Blair Kim, e DeLoache Shawn author, eds. Medikidz explain sickle cell disease. London: Medikidz Ltd., 2013.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Howard, Jo, e Paul Telfer. Sickle Cell Disease in Clinical Practice. London: Springer London, 2015. http://dx.doi.org/10.1007/978-1-4471-2473-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

National Heart, Lung, and Blood Institute. Division of Blood Diseases and Resources., ed. The Management of sickle cell disease. 4^a ed. Bethesda, MD: The Institute, 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

National Heart, Lung, and Blood Institute. Division of Blood Diseases and Resources. The management of sickle cell disease. 4^a ed. Bethesda, MD: The Institute, 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Midence, Kenny. Sickle cell disease: A psychosocial approach. Oxford: Radcliffe Medical Press, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Meier, Emily Riehm, Allistair Abraham e Ross M. Fasano, eds. Sickle Cell Disease and Hematopoietic Stem Cell Transplantation. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62328-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

1932-, Hurtig Anita Landau, e Viera Carol Therese 1952-, eds. Sickle cell disease: Psychological and psychosocial issues. Urbana: University of Illinois Press, 1986.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

N, Mankad Vipul, e Moore R. Blaine, eds. Sickle cell disease: Pathophysiology, diagnosis, and management. Westport, Conn: Praeger, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Ennis, Sylvia. The natural choice: Sickle cell disease/ thalassaemia. New Delhi: B.Jain Publishers, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Anionwu, Elizabeth N. Sickle cell disease: A guide for families. Harlow: Longman, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Samuel, Charache, Lubin Bertram, Reid Clarice D, United States. Dept. of Health and Human Services., National Institutes of Health (U.S.) e United States. Public Health Service., eds. Management and therapy of sickle cell disease. 3^a ed. [Bethesda, Md.]: U. S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Inusa, Baba, Kanayo Nwankwo, Nkechikwu Azinge-Egbiri e Bukola Bolarinwa. Sickle Cell Disease in Sub-Saharan Africa. London: Routledge, 2024. http://dx.doi.org/10.4324/9781003463931.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Inusa, Baba, Kanayo Nwankwo, Nkechikwu Azinge-Egbiri e Bukola Bolarinwa. Sickle Cell Disease in Sub-Saharan Africa. London: Routledge, 2024. http://dx.doi.org/10.4324/9781003467748.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

D, O'Malley Paul, ed. New developments in sickle cell disease research. New York: Nova Science Publishers, 2006.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

B, Jibril Harun, ed. Sickle cell disease: A guide for families. London: Collins, 1986.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Al-Jamʼa, Ali H. Management manual of sickel cell disease. [Saudi Arabia: Qatif Central Hospital], 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Rosse, Wendell F. Transfusion support for patients with sickle cell disease. Bethesda, Md: AABB Press, 1998.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Ng, Ann, e Erin S. Williams. Sickle Cell Disease. Editado por Erin S. Williams, Olutoyin A. Olutoye, Catherine P. Seipel e Titilopemi A. O. Aina. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190678333.003.0033.

Texto completo da fonte

Resumo:

Sickle cell anemia (sickle cell disease) is a common hemoglobinopathy with anywhere from 90,000 to 100,000 Americans affected. This chronic condition has a predominance in populations of African descent, occurring in approximately 1 out of 365 African American births, compared to 1 out of 16,300 Hispanic births. The sickle cell trait can be detected in 1 of 13 African American births. One of the most common complications associated with sickle cell anemia, vaso-occlusive crises by sickled cells, results in severe pain. Other issues associated with this condition include acute chest syndrome, lung infections, end organ damage, and stroke. With improvements in the management and prevention of pain crises, infection, and other systemic involvement, these patients are living longer, thus increasing the potential for surgical needs. Whether it is for routine surgeries or surgeries that are due to the natural history of the disease; the pediatric anesthesiologist must be knowledgeable of the management of these patients in order to prevent morbidity and mortality.

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Sickle Cell Disease (Diseases and Disorders). Lucent Books, 2007.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Vescia, Monique, e Virginia Silverstein. What You Can Do about Sickle Cell Disease. Enslow Publishing, LLC, 2015.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Szabova, Alexandra, e Kenneth R. Goldschneider. Sickle Cell Disease. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199764495.003.0040.

Texto completo da fonte

Resumo:

0.2% of African-Americans have sickle cell anemia while, with 8% to 10% have sickle cell trait. This chapter provides an overiew of the etiology, pathophysiology, and treatment of sickle cell anemia as they affect anesthetic management—before, during, and after surgery.

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Serjeant, Graham R. Sickle Cell Disease. Oxford University Press, USA, 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Anionwu, Elizabeth, e H. Jibril. Sickle Cell Disease. Longman, 1986.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Franklin, Andrew. Sickle Cell Disease. Editado por Matthew D. McEvoy e Cory M. Furse. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190226459.003.0084.

Texto completo da fonte

Resumo:

Sickle cell disease, a hemoglobinopathy that affects multiple organ systems, is a complex disease entity that presents unique challenges during the perioperative period. The hallmark of sickle cell disease, vaso-occlusion, results from sickling of erythrocytes containing hemoglobin of abnormal conformation due to genetically mutated beta globin genes. The perioperative clinician must properly care for acute sickle cell crises including acute painful episodes and acute chest syndrome, and safely care for the sickle cell patient through the preoperative, intraoperative, and postoperative phases of surgical treatment. Both acute painful episodes and acute chest syndrome result from vaso-occlusive crises, and early stabilization of these emergencies is crucial to ensuring a positive patient outcome. The singular perioperative objective for the care of sickle cell disease patients is both simple and daunting: to achieve physiologic homeostasis in patients with preexisting multiorgan dysfunction undergoing a series of physiologic insults during and after surgery.

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Ferrari, Lynne R. Sickle Cell Disease. Editado por Kirk Lalwani, Ira Todd Cohen, Ellen Y. Choi e Vidya T. Raman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190685157.003.0051.

Texto completo da fonte

Resumo:

Sickle cell anemia is a disease that combines molecular biology, clinical features, biochemistry, pathology, natural selection, population genetics, gene expression, and genomics and is the world’s most common life-threatening monogenic disorder. Clinical features include anemia; painful crisis especially in fingers, chest, and long bones; hemolysis; splenic infarction resulting in functional asplenia; and microinfarction leading to neurologic and renal impairment. The maintenance of adequate body temperature with active warming devices and warmed intravenous fluids, monitoring hydration and urine output, providing supplemental oxygen, and limiting surgical and anesthesia times to reduce pulmonary complications constitute the best management for patients with sickle cell disease.

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Anionwu, Elizabeth, e H. Jibril. Sickle Cell Disease. 2^a ed. Longman, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Sickle cell disease. 2^a ed. Oxford: Oxford University Press, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Erhabor, Osaro. Sickle Cell Disease. IntechOpen, 2022.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Sickle cell disease. Oxford: Oxford University Press, 1985.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Gladwin, Mark T., Gregory J. Kato e Enrico M. Novelli. Sickle Cell Disease. McGraw-Hill Education, 2021.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Alebiosu, Christopher Olutayo. Sickle Cell Disease. Cambridge Scholars Publishing, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Midence, Kenny. Sickle Cell Disease. Scovill-Paterson, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Batchelor, Tracy, Joshua P. Klein, Andrés José María Ferreri e Lisa M. DeAngelis, eds. Oxford Textbook of Neurohaematology. Oxford University PressOxford, 2024. http://dx.doi.org/10.1093/med/9780198884903.001.0001.

Texto completo da fonte

Resumo:

Abstract The Oxford Textbook of Neurohaematology is the first dedicated source of knowledge on the diverse neurological conditions associated with malignant and classical haematological diseases. The book is divided into three sections. In the first section, neurological conditions associated with malignant haematological diseases are covered. This section begins with chapters on primary haematological malignancies of the nervous system, including primary central nervous system lymphomas, vitreoretinal lymphoma, and other rare primary malignancies such as Hodgkin disease and lymphoproliferative disorders. Next, a chapter on histiocytic tumours of the central nervous system presents the neurological conditions associated with the Langerhans and non-Langerhans histiocytoses. This is followed by chapters covering the neurological complications of systemic myeloid and lymphoid malignancies. The second section of the book covers neurological complications of treatments used in the management of haematological malignancies such as chemotherapy, radiation, and immunotherapy, including chimeric antigen receptor T cells. The third and final section of the book features chapters on neurological complications associated with classical haematological diseases, including disorders of red blood cells (e.g. sickle cell anaemia), disorders of platelets and coagulation (e.g. immune thrombocytopenia), and disorders of white blood cells (e.g. hyperviscosity syndrome).

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Lance, Eboni I., e Andrew W. Zimmerman. Sickle Cell Anemia. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0079.

Texto completo da fonte

Resumo:

Sickle cell disease is a genetic hematological disorder involving red blood cells that become deformed when stressed. Patients with homozygous hemoglobin SS disease often have multiple systemic and neurologic complications, particularly stroke. Intellectual disability is commonly seen in the population, in patients with and without a history of stroke, attributed to different underlying mechanisms of brain injury. Autism is rare and not described in sickle cell disease in the literature to date. Many treatments (chronic transfusion therapy, hydroxyurea, bone marrow transplant) are in trials at this time to see if risk of stroke and other neurologic complications can be reduced (ClinicalTrials.gov identifiers: NCT01425307, NCT01389024, NCT00152113).

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

LaPierre, Yvette. Handling Sickle Cell Disease. ABDO Publishing Company, 2021.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Sickle Cell Disease Patient. Tettah-A'Domeno Co, 1998.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Bloom, Miriam. Understanding Sickle Cell Disease. University Press of Mississippi, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Lapierre, Yvette. Handling Sickle Cell Disease. Essential Library, 2021.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

GLADWIN. Sickle Cell Disease (ie). McGraw-Hill Education, 2021.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!